Semiannual Report — FY2026 H1
What Veritas In Silico Inc. reported for the period from 2026-01-01 to 2026-12-31.
Filed 2026-08-07View the original on EDINET
How much it says
58Typical
What moved here
27named for the first time
Its own wording
29terms
Which filing this is
6/ 6newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
During the interim accounting period from 1 January 2026 to 30 June 2026, collaborative drug discovery research using the aibVIS platform progressed. The joint research with Takeda Pharmaceutical Company Limited ended in April 2026, while the joint exploratory research agreement with SpiroChem AG was executed in May 2026. At the same time, interim net loss was ¥386,617 thousand due mainly to higher R&D expenses and the recognition of an impairment loss, and cash and cash equivalents stood at ¥430,305 thousand.
Komori's summary of this document, not the document's own words.58Typical
How much this filing saysA weighted roll-up of 11 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 35 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
93
Very detailed
68
Detailed
94
Very detailed
50
Typical
15
Almost nothing
68
Detailed
27
Almost nothing
31
Thin
53
Typical
55
Typical
50
Typical
R&D spend1億円Money spent making new things.
Cash left over1億円Cash from the business, less what went into equipment.
Spent on equipment1億円Plants, machines — things meant to last.
EmployeesNot disclosedThis document does not carry the figure.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.